Rce1: mechanism and inhibition

References

• Baell JB. 2016. Feeling nature’s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS). J Nat Prod. 79:616–628.
   PubMed Web of Science ®Google Scholar
• Baell JB, Ferrins L, Falk H, Nikolakopoulos G. 2013. PAINS: relevance to tool compound discovery and fragment-based screening. Aust J Chem. 66:1483–1494.
   Web of Science ®Google Scholar
• Baell JB, Holloway GA. 2010. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 53:2719–2740.
   PubMed Web of Science ®Google Scholar
• Baell JB, Walters MA. 2014. Chemistry: chemical con artists foil drug discovery. Nature. 513:481–483.
   PubMed Web of Science ®Google Scholar
• Baker RP, Young K, Feng L, Shi Y, Urban S. 2007. Enzymatic analysis of a rhomboid intramembrane protease implicates transmembrane helix 5 as the lateral substrate gate. Proc Natl Acad Sci USA. 104:8257–8262.
   PubMed Web of Science ®Google Scholar
• Ben-Shem A, Fass D, Bibi E. 2007. Structural basis for intramembrane proteolysis by rhomboid serine proteases. Proc Natl Acad Sci USA. 104:462–466.
   PubMed Web of Science ®Google Scholar
• Bergman JA, Majmudar JD, Gibbs RA, Hrycyna CA. 2011. Inhibitors of postprenylation CAAX processing enzymes. In: Tamanoi F, Hrycyna CA, Bergo M, editors. The enzymes, Vol. 30B. New York: Elsevier/Academic Press; p. 205–229.
   Google Scholar
• Bergo MO, Ambroziak P, Gregory C, George A, Otto JC, Kim E, Nagase H, Casey PJ, Balmain A, Young SG. 2002. Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Mol Cell Biol. 22:171–181.
   PubMed Web of Science ®Google Scholar
• Bergo MO, Lieu HD, Gavino BJ, Ambroziak P, Otto JC, Casey PJ, Walker QM, Young SG. 2004. On the physiological importance of endoproteolysis of CAAX proteins: heart-specific Rce1 knockout mice develop a lethal cardiomyopathy. J Biol Chem. 279:4729–4736.
   PubMed Web of Science ®Google Scholar
• Berndt N, Hamilton AD, Sebti SM. 2011. Targeting protein prenylation for cancer therapy. Nat Rev Cancer. 11:775–791.
   PubMed Web of Science ®Google Scholar
• Bond A, Reichert Z, Stivers JT. 2006. Novel and specific inhibitors of a poxvirus type I topoisomerase. Mol Pharmacol. 69:547–557.
   PubMed Web of Science ®Google Scholar
• Boyartchuk VL, Ashby MN, Rine J. 1997. Modulation of ras and a-factor function by carboxyl-terminal proteolysis. Science. 275:1796–1800.
   PubMed Web of Science ®Google Scholar
• Boyartchuk VL, Rine J. 1998. Roles of prenyl protein proteases in maturation of Saccharomyces cerevisiae a-factor. Genetics. 150:95–101.
   PubMed Web of Science ®Google Scholar
• Bracha-Drori K, Shichrur K, Lubetzky TC, Yalovsky S. 2008. Functional analysis of Arabidopsis postprenylation CaaX processing enzymes and their function in subcellular protein targeting. Plant Physiol. 148:119–131.
   PubMed Web of Science ®Google Scholar
• Burrows JF, Kelvin AA, McFarlane C, Burden RE, McGrattan MJ, De la Vega M, Govender U, Quinn DJ, Dib K, Gadina M, et al. 2009. USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. J Biol Chem. 284:9587–9595.
   PubMed Web of Science ®Google Scholar
• Cadiñanos J, Schmidt WK, Fueyo A, Varela I, López-Otín C, Freije JMP. 2003a. Identification, functional expression and enzymic analysis of two distinct CaaX proteases from Caenorhabditis elegans. Biochem J. 370:1047–1054.
   PubMed Web of Science ®Google Scholar
• Cadiñanos J, Varela I, Mandel DA, Schmidt WK, Diaz-Perales A, Lopez-Otin C, Freije JMP. 2003b. AtFACE-2, a functional prenylated protein protease from Arabidopsis thaliana related to mammalian Ras-converting enzymes. J Biol Chem. 278:42091–42097.
   PubMed Web of Science ®Google Scholar
• Chen Y. 1998. Inhibition of K-ras-transformed rodent and human cancer cell growth via induction of apoptosis by irreversible inhibitors of ras endoprotease. Cancer Lett. 131:191–200.
   PubMed Web of Science ®Google Scholar
• Chen Y. 1999. Selective inhibition of ras-transformed cell growth by a novel fatty acid-based chloromethyl ketone designed to target ras endoprotease. Ann NY Acad Sci. 886:103–108.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ma Y-T, Rando RR. 1996. Solubilization, partial purification, and affinity labeling of the membrane-bound isoprenylated protein endoprotease. Biochemistry. 35:3227–3237.
   PubMed Web of Science ®Google Scholar
• Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, Ivanov IE, Philips MR. 1999. Endomembrane trafficking of Ras: the CAAX motif targets proteins to the ER and Golgi. Cell. 98:69–80.
   PubMed Web of Science ®Google Scholar
• Christiansen JR, Kolandaivelu S, Bergo MO, Ramamurthy V. 2011. RAS-converting enzyme 1-mediated endoproteolysis is required for trafficking of rod phosphodiesterase 6 to photoreceptor outer segments. Proc Natl Acad Sci USA. 108:8862–8866.
   PubMed Web of Science ®Google Scholar
• Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a calcium-dependent translocation domain with homology to PKC and GAP. Cell. 65:1043–1051.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. 2017. [accessed 2017 Nov 6]. https://clinicaltrials.gov/ct2/results?cond=&term=Carboxyamidotriazole&cntry1=&state1=&Search=Search
   Google Scholar
• Coan KED, Shoichet BK. 2008. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. J Am Chem Soc. 130:9606–9612.
   PubMed Web of Science ®Google Scholar
• Corrado C, Flugy AM, Taverna S, Raimondo S, Guggino G, Karmali R, De Leo G, Alessandro R. 2012. Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis. PLoS One. 7:e42310.
   PubMed Web of Science ®Google Scholar
• Cox AD, Der CJ, Philips MR. 2015. Targeting RAS membrane association: back to the future for anti-RAS drug discovery? Clin Cancer Res. 21:1819–1827.
   PubMed Web of Science ®Google Scholar
• Craig KS, Williams DE, Hollander I, Frommer E, Mallon R, Collins K, Wojciechowicz D, Tahir A, Van Soest R, Andersen RJ. 2002. Novel sesterterpenoid and norsesterterpenoid RCE-protease inhibitors isolated from the marine sponge Hippospongia sp. Tetrahedr Lett. 43:4801–4804.
   Web of Science ®Google Scholar
• DeBonis S, Skoufias DA, Lebeau L, Lopez R, Robin G, Margolis RL, Wade RH, Kozielski F. 2004. In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities. Mol Cancer Ther. 3:1079–1090.
   PubMed Web of Science ®Google Scholar
• Dechert A-M, MacNamara JP, Breevoort SR, Hildebrandt ER, Hembree NW, Rea AC, McLain DE, Porter SB, Schmidt WK, Dore TM. 2010. Modulation of the inhibitor properties of (acyloxy)methyl ketones toward the CaaX proteases. Bioorg Med Chem. 18:6230–6237.
   PubMed Web of Science ®Google Scholar
• Dolence EK, Dolence JM, Poulter CD. 2000. Solid-phase synthesis of a farnesylated CaaX peptide library: inhibitors of the Ras CaaX endoprotease. J Comb Chem. 2:522–536.
   PubMedGoogle Scholar
• Dolence EK, Dolence JM, Poulter CD. 2001. Solid-phase synthesis of a radiolabeled, biotinylated, and farnesylated Ca1a2X peptide substrate for Ras- and a-mating factor converting enzyme. Bioconj Chem. 12:35–43.
   PubMed Web of Science ®Google Scholar
• Dolence JM, Steward LE, Dolence EK, Wong DH, Poulter CD. 2000. Studies with recombinant Saccharomyces cerevisiae CaaX prenyl protease Rce1p. Biochemistry. 39:4096–4104.
   PubMed Web of Science ®Google Scholar
• Dore TM, Schmidt WK. (2013). Isoprenylated protein peptidase Rce1p. In: Rawlings ND, Salvesen GS, editors. Handbook of proteolytic enzymes. 3rd ed., Vol. 2. Oxford, UK: Elsevier; p. 1720–1726.
   Google Scholar
• Dorjsuren D, Burnette A, Gray GN, Chen X, Zhu W, Roberts PE, Currens MJ, Shoemaker RH, Ricciardi RP, Sei S. 2006. Chemical library screen for novel inhibitors of Kaposi’s sarcoma-associated herpesvirus processive DNA synthesis. Antiviral Res. 69:9–23.
   PubMed Web of Science ®Google Scholar
• Ellermeier CD, Losick R. 2006. Evidence for a novel protease governing regulated intramembrane proteolysis and resistance to antimicrobial peptides in Bacillus subtilis. Genes Dev. 20:1911–1922.
   PubMed Web of Science ®Google Scholar
• Esher SK, Ost KS, Kozubowski L, Yang D-H, Kim MS, Bahn Y-S, Alspaugh JA, Nichols CB. 2016. Relative contributions of prenylation and postprenylation processing in Cryptococcus neoformans pathogenesis. mSphere. 1:e00084–15.
   PubMed Web of Science ®Google Scholar
• Felder CC, Ma AL, Liotta LA, Kohn EC. 1991. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharmacol Exp Ther. 257:967–971.
   PubMed Web of Science ®Google Scholar
• Feng L, Yan H, Wu Z, Yan N, Wang Z, Jeffrey PD, Shi Y. 2007. Structure of a site-2 protease family intramembrane metalloprotease. Science. 318:1608–1612.
   PubMed Web of Science ®Google Scholar
• Frankel MB, Wojcik BM, DeDent AC, Missiakas DM, Schneewind O. 2010. ABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureus. Mol Microbiol. 78:238–252.
   PubMed Web of Science ®Google Scholar
• Fueller F, Bergo MO, Young SG, Aktories K, Schmidt G. 2006. Endoproteolytic processing of RhoA by Rce1 is required for the cleavage of RhoA by Yersinia enterocolitica outer protein T. Infect Immun. 74:1712–1717.
   PubMed Web of Science ®Google Scholar
• Fujinaga M, Cherney MM, Oyama H, Oda K, James MNG. 2004. The molecular structure and catalytic mechanism of a novel carboxyl peptidase from Scytalidium lignicolum. Proc Natl Acad Sci USA. 101:3364–3369.
   PubMed Web of Science ®Google Scholar
• Gao J, Liao J, Yang G-Y. 2009. CAAX-box protein, prenylation process and carcinogenesis. Am J Transl Res. 1:312–325.
   PubMed Web of Science ®Google Scholar
• Gavande NS, VanderVere-Carozza PS, Pawelczak KS, Turchi JJ. (2016). Targeting the nucleotide excision repair pathway for therapeutic applications. In: Kelley MR, Fishel ML, editors. DNA repair in cancer therapy. 2nd ed. London: Academic Press; p. 135–150.
   Google Scholar
• Gelb MH, Brunsveld L, Hrycyna CA, Michaelis S, Tamanoi F, Van Voorhis WC, Waldmann H. 2006. Therapeutic intervention based on protein prenylation and associated modifications. Nat Chem Biol. 2:518–528.
   PubMed Web of Science ®Google Scholar
• Gelb MH, Van Voorhis WC, Buckner FS, Yokoyama K, Eastman R, Carpenter EP, Panethymitaki C, Brown KA, Smith DF. 2003. Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol Biochem Parasitol. 126:155–163.
   PubMed Web of Science ®Google Scholar
• Gentry LR, Nishimura A, Cox AD, Martin TD, Tsygankov D, Nishida M, Elston TC, Der CJ. 2015. Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases. J Biol Chem. 290:22851–22861.
   PubMed Web of Science ®Google Scholar
• Gillespie JR, Yokoyama K, Lu K, Eastman RT, Bollinger JG, Van Voorhis WC, Gelb MH, Buckner FS. 2007. C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins. Mol Biochem Parasitol. 153:115–124.
   PubMed Web of Science ®Google Scholar
• Grover GJ, Kelly J, Moore G, JAcoby H, Karmali RA, Gorman GS. 2007. Comparative pharmacokinetic profile of carboxyamidotriazole and carboxyamidotriazoleorotate. Cancer Ther. 5:437–442.
   Google Scholar
• Guo L, Li ZS, Wang HL, Ye CY, Zhang DC. 2006. Carboxyamidotriazole inhibits proliferation of human breast cancer cells via G2/M cell cycle arrest and apoptosis. Eur J Pharmacol. 538:15–22.
   PubMed Web of Science ®Google Scholar
• Gusovsky F, Lueders JE, Kohn EC, Felder CC. 1993. Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma. An alternative mechanism for cholinergic-induced phosphoinositide breakdown. J Biol Chem. 268:7768–7772.
   PubMed Web of Science ®Google Scholar
• Hancock JF, Cadwallader K, Paterson H, Marshall CJ. 1991. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J. 10:4033–4039.
   PubMed Web of Science ®Google Scholar
• Hancock JF, Peterson H, Marshall CJ. 1990. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell. 63:133–139.
   PubMed Web of Science ®Google Scholar
• Hanker AB, Mitin N, Wilder RS, Henske EP, Tamanoi F, Cox AD, Der CJ. 2010. Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling. Oncogene. 29:380–391.
   PubMed Web of Science ®Google Scholar
• Hildebrandt ER, Arachea BT, Wiener MC, Schmidt WK. 2016a. Ste24p mediates proteolysis of both isoprenylated and non-prenylated oligopeptides. J Biol Chem. 291:14185–14198.
   PubMed Web of Science ®Google Scholar
• Hildebrandt ER, Cheng M, Zhao P, Kim JH, Wells L, Schmidt WK. 2016b. A shunt pathway limits the CaaX processing of Hsp40 Ydj1p and regulates Ydj1p-dependent phenotypes. eLife 5:e15899.
   PubMed Web of Science ®Google Scholar
• Hildebrandt ER, Davis DM, Deaton J, Krishnankutty RK, Lilla E, Schmidt WK. 2013. Topology of the yeast Ras converting enzyme as inferred from cysteine accessibility studies. Biochemistry. 52:6601–6614.
   PubMed Web of Science ®Google Scholar
• Hollander I, Frommer E, Mallon R. 2000. Human Ras-converting enzyme (hRCE1) endoproteolytic activity on K-Ras-derived peptides. Anal Biochem. 286:129–137.
   PubMed Web of Science ®Google Scholar
• Hollander IJ, Frommer E, Aulabaugh A, Mallon R. 2003. Human Ras converting enzyme endoproteolytic specificity at the P2’ and P3’ positions of K-Ras-derived peptides. Biochim Biophys Acta. 1649:24–29.
   PubMedGoogle Scholar
• Huang L, Li M, Wang D, He J, Wu W, Zeng Q, Li J, Xiao M, Hu J, He Y, et al. 2016. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer. Hum Pathol. 47:109–114.
   PubMed Web of Science ®Google Scholar
• Hupe DJ, Boltz R, Cohen CJ, Felix J, Ham E, Miller D, Soderman D, Van Skiver D. 1991. The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582. J Biol Chem. 266:10136–10142.
   PubMed Web of Science ®Google Scholar
• Jaworski J, Govender U, McFarlane C, de la Vega M, Greene MK, Rawlings ND, Johnston JA, Scott CJ, Burrows JF. 2014. A novel RCE1 isoform is required for H-Ras plasma membrane localization and is regulated by USP17. Biochem J. 457:289–300.
   PubMed Web of Science ®Google Scholar
• Jenkins JL, Kao RYT, Shapiro R. 2002. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin. Proteins Struct Funct Genet. 50:81–93.
   Web of Science ®Google Scholar
• Kao RYT, Jenkins JL, Olson KA, Key ME, Fett JW, Shapiro R. 2002. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci USA. 99:10066–10071.
   PubMed Web of Science ®Google Scholar
• Kim E, Ambroziak P, Otto JC, Taylor B, Ashby M, Shannon K, Casey PJ, Young SG. 1999. Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells. J Biol Chem. 274:8383–8390.
   PubMed Web of Science ®Google Scholar
• Kjos M, Snipen L, Salehian Z, Nes IF, Diep DB. 2010. The Abi proteins and their involvement in bacteriocin self-immunity. J Bacteriol. 192:2068–2076.
   PubMed Web of Science ®Google Scholar
• Kohn EC, Felder CC, Jacobs W, Holmes KA, Day A, Freer R, Liotta LA. 1994a. Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res. 54:935–942.
   PubMed Web of Science ®Google Scholar
• Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG, Liotta LA. 1994b. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem. 269:21505–21511.
   PubMed Web of Science ®Google Scholar
• Kohn EC, Liotta LA. 1990. L651582: a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst. 82:54–60.
   PubMed Web of Science ®Google Scholar
• Kohn EC, Sandeen MA, Liotta LA. 1992. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res. 52:3208–3212.
   PubMed Web of Science ®Google Scholar
• Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. 2007. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov. 6:541–555.
   PubMed Web of Science ®Google Scholar
• Krishnankutty RK, Kukday SS, Castleberry AJ, Breevoort SR, Schmidt WK. 2009. Proteolytic processing of certain CaaX motifs can occur in the absence of the Rce1p and Ste24p CaaX proteases. Yeast. 26:451–463.
   PubMed Web of Science ®Google Scholar
• Li J, Wang D, Liu J, Qin Y, Huang L, Zeng Q, Xiao M, Hu J, Yang Q, He J, et al 2017. Rce1 expression in renal cell carcinoma and its regulatory effect on 786-O cell apoptosis through endoplasmic reticulum stress. Acta Biochim Biophys Sin. 49:254–261.
   Google Scholar
• Lu Y, Nikolovska-Coleska Z, Fang X, Gao W, Shangary S, Qiu S, Qin D, Wang S. 2006. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J Med Chem. 49:3759–3762.
   PubMed Web of Science ®Google Scholar
• Ma YT, Gilbert BA, Rando RR. 1993. Inhibitors of the isoprenylated protein endoprotease. Biochemistry. 32:2386–2393.
   PubMed Web of Science ®Google Scholar
• Manandhar SP, Hildebrandt ER, Jacobsen WH, Santangelo GM, Schmidt WK. 2010. Chemical inhibition of CaaX protease activity disrupts yeast Ras localization. Yeast. 27:327–343.
   PubMed Web of Science ®Google Scholar
• Manandhar SP, Hildebrandt ER, Schmidt WK. 2007. Small-molecule inhibitors of the Rce1p CaaX protease. J Biomol Screen. 12:983–993.
   PubMedGoogle Scholar
• Manolaridis I, Kulkarni K, Dodd RB, Ogasawara S, Zhang Z, Bineva G, Reilly NO, Hanrahan SJ, Thompson AJ, Cronin N, et al. 2013. Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1. Nature. 504:301–305.
   PubMed Web of Science ®Google Scholar
• McGovern SL, Caselli E, Grigorieff N, Shoichet BK. 2002. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem. 45:1712–1722.
   PubMed Web of Science ®Google Scholar
• McGovern SL, Helfand BT, Feng B, Shoichet BK. 2003. A specific mechanism of nonspecific inhibition. J Med Chem. 46:4265–4272.
   PubMed Web of Science ®Google Scholar
• Michaelson D, Ali W, Chiu VK, Bergo M, Silletti J, Wright L, Young SG, Philips M. 2005. Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases. Mol Biol Cell. 16:1606–1616.
   PubMed Web of Science ®Google Scholar
• Michaelson D, Silletti J, Murphy G, D’Eustachio P, Rush M, Philips MR. 2001. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J Cell Biol. 152:111–126.
   PubMed Web of Science ®Google Scholar
• Mignen O, Brink C, Enfissi A, Nadkarni A, Shuttleworth TJ, Giovannucci DR, Capiod T. 2005. Carboxyamidotriazole-induced inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells. J Cell Sci. 118:5615–5623.
   PubMed Web of Science ®Google Scholar
• Mohammed I, Hampton SE, Ashall L, Hildebrandt ER, Kutlik RA, Manandhar SP, Floyd BJ, Smith HE, Dozier JK, Distefano MD, et al. 2016. 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells. Bioorg Med Chem. 24:160–178.
   PubMed Web of Science ®Google Scholar
• Mokry DZ, Manandhar SP, Chicola KA, Santangelo GM, Schmidt WK. 2009. Heterologous expression studies of Saccharomyces cerevisiae reveal two distinct trypanosomatid CaaX protease activities and identify their potential targets. Eukaryot Cell. 8:1891–1900.
   PubMedGoogle Scholar
• Monne M, Nilsson I, Elofsson A, von Heijne G. 1999. Turns in transmembrane helices: determination of the minimal length of a “Helical Hairpin” and derivation of a fine-grained turn propensity scale. J Mol Biol. 293:807–814.
   PubMed Web of Science ®Google Scholar
• Norholm MHH, Shulga YV, Aoki S, Epand RM, von Heijne G. 2011. Flanking residues help determine whether a hydrophobic segment adopts a monotopic or bitopic topology in the endoplasmic reticulum membrane. J Biol Chem. 286:25284–25290.
   PubMed Web of Science ®Google Scholar
• Otto JC, Kim E, Young SG, Casey PJ. 1999. Cloning and characterization of a mammalian prenyl protein-specific protease. J Biol Chem. 274:8379–8382.
   PubMed Web of Science ®Google Scholar
• Peach KC, Bray WM, Shikuma NJ, Gassner NC, Lokey RS, Yildiz FH, Linington RG. 2011. An image-based 384-well high-throughput screening method for the discovery of biofilm inhibitors in Vibrio cholerae. Mol BioSyst. 7:1176–1184.
   PubMed Web of Science ®Google Scholar
• Pei J, Grishin NV. 2001. Type II CAAX prenyl endopeptidases belong to a novel superfamily of putative membrane-bound metalloproteases. Trends Biochem Sci. 26:275–277.
   PubMed Web of Science ®Google Scholar
• Pei J, Mitchell DA, Dixon JE, Grishin NV. 2011. Expansion of type II CAAX proteases reveals evolutionary origin of γ-secretase subunit APH-1. J Mol Biol. 410:18–26.
   PubMed Web of Science ®Google Scholar
• Plummer LJ, Hildebrandt ER, Porter SB, Rogers VA, McCracken J, Schmidt WK. 2006. Mutational analysis of the Ras converting enzyme reveals a requirement for glutamate and histidine residues. J Biol Chem. 281:4596–4605.
   PubMed Web of Science ®Google Scholar
• Porter SB, Hildebrandt ER, Breevoort SR, Mokry DZ, Dore TM, Schmidt WK. 2007. Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. Biochim Biophys Acta. 1773:853–862.
   PubMed Web of Science ®Google Scholar
• Price CTD, Al-Quadan T, Santic M, Jones SC, Abu Kwaik Y. 2010. Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila. J Exp Med. 207:1713–1726.
   PubMed Web of Science ®Google Scholar
• Prior IA, Lewis PD, Mattos C. 2012. A comprehensive survey of Ras mutations in cancer. Cancer Res. 72:2457–2467.
   PubMed Web of Science ®Google Scholar
• Pryor EE, Jr., Horanyi PS, Clark KM, Fedoriw N, Connelly SM, Koszelak-Rosenblum M, Zhu G, Malkowski MG, Wiener MC, Dumont ME. 2013. Structure of the integral membrane protein CAAX protease Ste24p. Science (Washington, DC). 339:1600–1604.
   PubMed Web of Science ®Google Scholar
• Quigley A, Dong YY, Pike ACW, Dong L, Shrestha L, Berridge G, Stansfeld PJ, Sansom MS, Edwards AM, Bountra C, et al. 2013. The structural basis of ZMPSTE24-dependent laminopathies. Science (Washington, DC). 339:1604–1607.
   PubMed Web of Science ®Google Scholar
• Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, Der CJ. 2008. Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem. 283:25150–25163.
   PubMed Web of Science ®Google Scholar
• Schlicker C, Rauch A, Hess KC, Kachholz B, Levin LR, Buck J, Steegborn C. 2008. Structure-based development of novel adenylyl cyclase inhibitors. J Med Chem. 51:4456–4464.
   PubMedGoogle Scholar
• Schlitzer M, Winter-Vann A, Casey PJ. 2001. Non-peptidic, non-prenylic inhibitors of the prenyl protein-specific protease Rce1. Bioorg Med Chem Lett. 11:425–427.
   PubMed Web of Science ®Google Scholar
• Schmidt WK, Dore TM. 2011. The Ras converting enzyme (Rce1p): orthologs, enzymology, and inhibitors. In: Tamanoi F, Hrycyna CA, Bergo M, editors. The enzymes, Vol. 30B. New York: Elsevier/Academic Press; p. 231–258.
   Google Scholar
• Schmidt WK, Tam A, Fujimura-Kamada K, Michaelis S. 1998. Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxyl-terminal CAAX protein processing and amino-terminal a-factor cleavage. Proc Natl Acad Sci USA. 95:11175–11180.
   PubMed Web of Science ®Google Scholar
• Shi B, Zhou X, Liang M, Luo Y, He L, Jiang P. 2017. Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma. BMC Cancer. 17:414.
   PubMed Web of Science ®Google Scholar
• Sierecki E, Newton AC. 2014. Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase. Biochemistry. 53:3971–3981.
   PubMed Web of Science ®Google Scholar
• Silvius JR. 2002. Mechanisms of Ras protein targeting in mammalian cells. J Membr Biol. 190:83–92.
   PubMed Web of Science ®Google Scholar
• Stein V, Kubala MH, Steen J, Grimmond SM, Alexandrov K. 2015. Towards the systematic mapping and engineering of the protein prenylation machinery in Saccharomyces cerevisiae. PLoS One. 10:e0120716.
   PubMed Web of Science ®Google Scholar
• Tam A, Nouvet FJ, Fujimura-Kamada K, Slunt H, Sisodia SS, Michaelis S. 1998. Dual roles for Ste24p in yeast a-factor maturation: NH2-terminal proteolysis and COOH-terminal CAAX processing. J Cell Biol. 142:635–649.
   PubMed Web of Science ®Google Scholar
• Tam A, Schmidt WK, Michaelis S. 2001. The multispanning membrane protein Ste24p catalyzes CAAX proteolysis and NH2-terminal processing of the yeast a-factor precursor. J Biol Chem. 276:46798–46806.
   PubMed Web of Science ®Google Scholar
• Taylor MH, Sandler A, Urba WJ, Omuro AMP, Gorman GS, Karmali RA. 2015. Effect of carboxyamidotriazole orotate, a modulator of calcium-dependent signaling pathways, on advanced solid tumors. J Cancer Ther. 6:322–333.
   Google Scholar
• Thorne N, Auld DS, Inglese J. 2010. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol. 14:315–324.
   PubMed Web of Science ®Google Scholar
• Tissue Expression of RCE1, The Human Protein Atlas. 2017. [accessed 2017 Nov 12]. https://www.proteinatlas.org/ENSG00000173653-RCE1/tissue
   Google Scholar
• Trueblood CE, Boyartchuk VL, Picologlou EA, Rozema D, Poulter CD, Rine J. 2000. The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities. Mol Cell Biol. 20:4381–4392.
   PubMed Web of Science ®Google Scholar
• Turk S, Kovac A, Boniface A, Bostock JM, Chopra I, Blanot D, Gobec S. 2009. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening. Bioorg Med Chem. 17:1884–1889.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstroem BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, et al. 2015. Proteomics. Tissue-based map of the human proteome. Science (Washington, DC). 347:1260419.
   PubMed Web of Science ®Google Scholar
• Vinothkumar KR, Strisovsky K, Andreeva A, Christova Y, Verhelst S, Freeman M. 2010. The structural basis for catalysis and substrate specificity of a rhomboid protease. EMBO J. 29:3797–3809.
   PubMed Web of Science ®Google Scholar
• Wahlstrom AM, Cutts BA, Karlsson C, Andersson KME, Liu M, Sjogren A-KM, Swolin B, Young SG, Bergo MO. 2007. Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease. Blood. 109:763–768.
   PubMed Web of Science ®Google Scholar
• Wang M, Casey PJ. 2016. Protein prenylation: unique fats make their mark on biology. Nat Rev Mol Cell Biol. 17:110–122.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ha Y. 2007. Open-cap conformation of intramembrane protease GlpG. Proc Natl Acad Sci USA. 104:2098–2102.
   PubMed Web of Science ®Google Scholar
• Williams DE, Hollander I, Feldberg L, Frommer E, Mallon R, Tahir A, van Soest R, Andersen RJ. 2009. Scalarane-based sesterterpenoid RCE-protease inhibitors isolated from the Indonesian marine sponge Carteriospongia foliascens. J Nat Prod. 72:1106–1109.
   PubMed Web of Science ®Google Scholar
• Winter-Vann AM, Casey PJ. 2005. Post-prenylation-processing enzymes as new targets in oncogenesis. Nat Rev Cancer. 5:405–412.
   PubMed Web of Science ®Google Scholar
• Xiang S, Bai W, Bepler G, Zhang X. 2017. Activation of Ras by post-translational modification. In: Azmi AS, editor. Conquering RAS: from biology to cancer therapy. London: Academic Press; p. 97–118.
   Google Scholar
• Young SG, Ambroziak P, Kim E, Clarke S. 2001. Postisoprenylation protein processing: CXXX (CaaX) endoproteases and isoprenylcysteinecarboxyl methyltransferase. In: Tamanoi F, Sigman DS, editors. The enzymes, Vol. 22. New York: Academic Press; p. 155–213.
   Google Scholar
• Young SG, Fong LG, Michaelis S. 2005. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria-new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res. 46:2531–2558.
   PubMed Web of Science ®Google Scholar